Relationship between final adult height and birth weight after gonadotropin-releasing hormone agonist treatment in girls with central precocious puberty
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Purpose: The clinical significance of birth weight relative to gestational age in girls with central precocious puberty is unclear. This study sought to compare clinical parameters such as final adult height (FAH) and menarche onset after treatment with gonadotropin-releasing hormone agonist (GnRHa) on birth weight in girls with central precocious puberty treated. Methods: This retrospective study reviewed data of 69 girls with precocious puberty who had reached their FAH in a long-term trial of GnRHa treatment between January 2007 and December 2017. The subjects were divided into small for gestational age (SGA) (n=19) and appropriate for gestational age (AGA) (n=50) groups. Results: When starting GnRHa treatment, bone age was 10.9±0.9 and 10.3±0.8 years in the SGA and AGA groups, respectively (P<0.05). The predicted adult height (PAH) (established according to the Bayley-Pinneau average table) and advanced PAH (established according to the Bayley-Pinneau advanced table) were 151.5±4.8 cm and 155.8±4.9 cm in the SGA group, respectively, and 153.4±5.3 cm and 159.0±6.0 cm in the AGA group. After treatment, no significant difference in bone age was found between the groups. The time to menarche after treatment was 12.5±7.6 and 21.1±12.3 months in the SGA and AGA groups, respectively (P<0.05). FAH in the SGA and AGA groups was 161.0±4.7 cm and 161.6±5.0 cm, respectively, without a significant difference. Conclusion: SGA girls with precocious puberty have increased bone age and earlier menarche relative to AGA girls. However, no difference in FAH after treatment was found between these groups.
Abstract
Purpose: The clinical significance of birth weight relative to gestational age in girls with central precocious puberty is unclear. This study sought to compare clinical parameters such as final adult height (FAH) and menarche onset after treatment with gonadotropin-releasing hormone agonist (GnRHa) on birth weight in girls with central precocious puberty treated. Methods: This retrospective study reviewed data of 69 girls with precocious puberty who had reached their FAH in a long-term trial of GnRHa treatment between January 2007 and December 2017. The subjects were divided into small for gestational age (SGA) (n=19) and appropriate for gestational age (AGA) (n=50) groups. Results: When starting GnRHa treatment, bone age was 10.9±0.9 and 10.3±0.8 years in the SGA and AGA groups, respectively (P<0.05). The predicted adult height (PAH) (established according to the Bayley-Pinneau average table) and advanced PAH (established according to the Bayley-Pinneau advanced table) were 151.5±4.8 cm and 155.8±4.9 cm in the SGA group, respectively, and 153.4±5.3 cm and 159.0±6.0 cm in the AGA group. After treatment, no significant difference in bone age was found between the groups. The time to menarche after treatment was 12.5±7.6 and 21.1±12.3 months in the SGA and AGA groups, respectively (P<0.05). FAH in the SGA and AGA groups was 161.0±4.7 cm and 161.6±5.0 cm, respectively, without a significant difference. Conclusion: SGA girls with precocious puberty have increased bone age and earlier menarche relative to AGA girls. However, no difference in FAH after treatment was found between these groups.
참고문헌 (21)
- Carel JC, "Clinical practice. Precocious puberty", N Engl J Med, 358, pp.2366~2377 (2008)
- Bertelloni S, "Effect of central precocious puberty and gonadotropinreleasing hormone analogue treatment on peak bone mass and final height in females", Eur J Pediatr, 157, pp.363~367 (1998)
- Lahlou N, "Pharmacokinetics and pharmacodynamics of GnRH agonists : clinical implications in pediatrics", J Pediatr Endocrinol Metab, 13(Suppl 1), pp.723~737 (2000)
- 정모경, "Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone agonist with or without growth hormone", Annals of Pediatric Endocrinology & Metabolism, 19(4), pp.214~219 (2014), 대한소아내분비학회
- Ying Y, "GnRH agonist treatment for idiopathic central precocious puberty can improve final adult height in Chinese girls", Oncotarget, 8, pp.109061~109067 (2017)
- 김세영, "부당경량아에서의 성장과 성 발달", Clinical and Experimental Pediatrics, 52(2), pp.142~151 (2009), 대한소아청소년과학회
- Albertsson-Wikland K, "Growth hormone treatment in short children", Acta Paediatr Scand Suppl, 325, pp.64~70 (1986)
- Hokken-Koelega AC, "Children born small for gestational age : do they catch up", Pediatr Res, 38, pp.267~271 (1995)
- Ibáñez L, "Early puberty-menarche after precocious pubarche : relation to prenatal growth", Pediatrics, 117, pp.117~121 (2006)
- Persson I, "Influence of perinatal factors on the onset of puberty in boys and girls : implications for interpretation of link with risk of long term diseases", Am J Epidemiol, 150, pp.747~755 (1999)
- Hernández MI, "Comparison of clinical, ultrasonographic, and biochemical differences at the beginning of puberty in healthy girls born either small for gestational age or appropriate for gestational age: preliminary results", J Clin Endocrinol Metab, 91, pp.3377~3381 (2006)
- Veening MA, "Pubertal development in children born small for gestational age", J Pediatr Endocrinol Metab, 17, pp.1497~1505 (2004)
- Greulich WW, "Radiographic atlas of skeletal development of the hand and wrist" (1971), Stanford University Press
- Bayley N, "Tables for predicting adult height from skeletal age : revised for use with the Greulich-Pyle hand standards", J Pediatr, 40, pp.423~441 (1952)
- Lazar L, "Pubertal course of persistently short children born small for gestational age (SGA) compared with idiopathic short children born appropriate for gestational age (AGA)", Eur J Endocrinol, 149, pp.425~432 (2003)
- Ibáñez L, "Early puberty : rapid progression and reduced final height in girls with low birth weight", Pediatrics, 106, pp.E72~ (2000)
- Hernández MI, "Pubertal development in girls born small for gestational age", J Pediatr Endocrinol Metab, 21, pp.201~208 (2008)
- Hofman PL, "Insulin resistance in short children with intrauterine growth retardation", J Clin Endocrinol Metab, 82, pp.402~406 (1997)
- Cara JF, "Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells", Endocrinology, 123, pp.733~739 (1988)
- Lee HS, "Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty", PLoS One, 13, pp.e0201906~ (2018)
- Tanaka T, "Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty", J Clin Endocrinol Metab, 90, pp.1371~1376 (2005)
